Detalles de la búsqueda
1.
Prognostic significance of circulating tumor cells and tumor related transcripts in small cell lung cancer: A step further to clinical implementation.
Int J Cancer
; 154(12): 2189-2199, 2024 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38353516
2.
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis.
Int J Mol Sci
; 25(7)2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38612799
3.
Effect of short-term storage of blood samples on gene expression in lung cancer patients.
Clin Chem Lab Med
; 61(2): 294-301, 2023 01 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36395488
4.
Alectinib following brigatinib: an efficient sequence for the treatment of advanced anaplastic lymphoma kinase-positive lung cancer patients.
Anticancer Drugs
; 32(1): 105-110, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32868645
5.
Treatment of ALK-rearranged non-small-cell lung cancer with brigatinib as second or later lines: real-world observations from a single institution.
Anticancer Drugs
; 30(7): e0787, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31305295
6.
The Landsteiner lung cancer research platform (LALUCA) : Objectives, methodology and implementation of a real-world clinical lung cancer registry.
Wien Klin Wochenschr
; 2024 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38652311
7.
Effectiveness of Outpatient Pulmonary Rehabilitation in Patients with Surgically Resected Lung Cancer: A Retrospective Real-World Analysis.
Cancers (Basel)
; 14(14)2022 Jul 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35884540
8.
Characteristics and Treatment Outcomes in Advanced-Stage Non-Small Cell Lung Cancer Patients with a KRAS G12C Mutation: A Real-World Study.
J Clin Med
; 11(14)2022 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35887862
9.
Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program.
Ther Adv Med Oncol
; 14: 17588359221103206, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35720834
10.
Detection of EGFR Activating and Resistance Mutations by Droplet Digital PCR in Sputum of EGFR-Mutated NSCLC Patients.
Clin Med Insights Oncol
; 15: 1179554921993072, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33642890
11.
Cancer Stem Cell-Like Circulating Tumor Cells Are Prognostic in Non-Small Cell Lung Cancer.
J Pers Med
; 11(11)2021 Nov 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34834576
12.
Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program.
Ther Adv Med Oncol
; 13: 17588359211019675, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34178121
13.
Later-Line Treatment with Lorlatinib in ALK- and ROS1-Rearrangement-Positive NSCLC: A Retrospective, Multicenter Analysis.
Pharmaceuticals (Basel)
; 13(11)2020 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33171712
14.
Molecular Characterization of Circulating Tumor Cells Enriched by A Microfluidic Platform in Patients with Small-Cell Lung Cancer.
Cells
; 8(8)2019 08 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31412616
15.
Comparison of RECIST, iRECIST, and PERCIST for the Evaluation of Response to PD-1/PD-L1 Blockade Therapy in Patients With Non-Small Cell Lung Cancer.
Clin Nucl Med
; 44(7): 535-543, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31021918
Resultados
1 -
15
de 15
1
Próxima >
>>